中药“异位康”颗粒治疗子宫内膜异位症的研究  

作　　者：张慧琴[1] 赵淑萍[1] 尹亚童 

机构地区：[1]山东青岛大学医学院附属医院妇科,266000 [2]山东青岛市妇幼保健所,266000

出　　处：《中外妇儿健康（学术版）》2010年第11期63-65,共3页

摘　　要：目的:探讨中药"异位康"颗粒治疗子宫内膜异位症(endometriosis EMT)的临床效果及作用机制。方法:EMT患者100例,随机分为2组,治疗组50例,给予"异位康"颗粒口服,对照组50例给予丹那唑(Danazol)口服,观察两组治疗前后患者症状体征改善情况、血清免疫球蛋白含量、补体C3含量、变化。结果:治疗组能显著改善患者症状和体征,总有效率84%。两组治疗结果相比差异无显著性,P>0.05。治疗组体液免疫IgG、IgA、IgM、C_3水平治疗后明显下降,差异有显著性(P<0.01)。结论:中药"异位康"颗粒是治疗EMT的有效方法,值得推广。To Study the therapeutic effect of Chinese medicine. Yiweikang and Denoval on endometriosis. Method： One hundred patients with endometriosis were randomly divided into two groups in equal, one group accepted yiweikang and the other with Denoval. We observed the variation of the clinical effects, immune globulin and complementC3 content. Result：The clinical effects had been improved in patients with endometriosis. The total effective rate of yiweikang reaches 84%, while no statistic difference between the treatment group and the control. （p〉0.05）. It shows a statistically decrease in the treatment group between pre and post therapy on the level of IgG,IgA,IgM and C3 （P〈0.01）. Conclusion： Yiweikang is a effectual raedicine to treat endometriosis. It worth to be extended.

关 键 词：子宫内膜异位症 中药异位康 丹那唑 

分 类 号：R711.3[医药卫生—妇产科学]